Kopran Limited

NSE: KOPRAN BSE: 524280 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

194 0(0%)

Volume

Open

High

Low

194

VWAP

52 Week High

214

52 Week Low

107

Viand Research Rating

Quality Score

00/00

Growth Score

00/00

Valuation Score

00/00

Momentum Score

00/00

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

938

No. of Shares

4.82

P/E

30.73

P/B

2.56

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

8.32

ROCE

Profit Growth

Listing Date

09-Jun-99

Promoter Holding

44.43%

FII Holding

0.36%

DII Holding

Price Chart

Price Performance

1 Week0

1 Month0

3 Months0

6 Months0

1 Year0

YTD0

Moving Average

5 Day SMA0

10 Day SMA0

20 Day SMA0

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3
Resistance 2
Resistance 1
Pivot Point
Support 1
Support 2
Support 3

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	Div Yld %
1	SUNPHARMA	4,42,187	1843	2%	14%	2%	9%	39	0	0	0
2	DIVISLAB	1,80,280	6791	2%	6%	4%	1%	65	0	0	0
3	TORNTPHARM	1,53,281	4529	0%	8%	18%	40%	64	0	0	0
4	APOLLOHOSP	1,19,047	8280	3%	7%	12%	17%	58	0	0	0
5	CIPLA	1,14,869	1422	1%	10%	7%	4%	22	0	0	0
6	DRREDDY	1,11,015	1330	0%	1%	7%	7%	20	0	0	0
7	ZYDUSLIFE	1,09,378	1087	6%	16%	15%	17%	20	0	0	0
8	LUPIN	1,04,017	2275	1%	2%	9%	15%	23	0	0	0
9	MANKIND	1,00,482	2434	3%	7%	7%	2%	49	0	0	0
10	MAXHEALTH	96,867	995	7%	1%	15%	14%	0	0	0	0
Load More

Shareholding Pattern (%)

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 44.43%	(0.01) 44.43%	(0.01) 44.43%	(0.01) 44.42%	(0.01) 44.45%	(0.01) 44.49%	(0.01) 44.49%	(0.01) 44.49%	(0.01) 44.49%	(0.01) 44.49%	(0.21) 44.49%	(0.01) 44.29%	(0.01) 44.29%	(0.01) 44.25%	(0.01) 44.25%	(0.51) 44.25%	(0.01) 43.78%	(0.01) 43.78%
FIIs	(-0.21) 0.36%	(-0.21) 0.60%	(-0.41) 0.76%	(0.31) 1.11%	(-0.51) 0.86%	(0.61) 1.31%	(-0.21) 0.68%	(0.41) 0.84%	(0.11) 0.48%	(0.11) 0.39%	(-0.11) 0.34%	(0.11) 0.41%	(-0.21) 0.34%	(0.01) 0.51%	(0.01) 0.50%	(-0.21) 0.53%	(0.51) 0.75%	(0.01) 0.27%
DIIs	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.21) 0.00%	(0.11) 0.22%	(-1.11) 0.14%	(1.11) 1.20%	(-0.21) 0.14%	(0.21) 0.35%	(0.01) 0.14%	(0.01) 0.14%	(0.01) 0.14%	(0.01) 0.14%	(0.01) 0.13%	(0.01) 0.14%	(-0.31) 0.16%	(0.01) 0.46%
Public	55.21%	54.99%	54.81%	54.45%	54.68%	53.98%	54.68%	53.47%	54.88%	54.78%	55.03%	55.15%	55.22%	55.09%	55.11%	55.07%	55.31%	55.50%
No. of Shareholders	60,886	62,222	60,194	58,652	60,560	57,154	51,492	50,850	51,636	53,791	44,038	41,567	42,034	41,768	40,883	39,906	37,822	38,195

Quarterly Results

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	194.28	117.91	135.22	172.36	166.24	151.56	139.44	186.08	158.92	152.59	117	148.88	158	116.97	125.62	142.83	132	127.57	75
Expenses	176.52	123.19	121.09	155.27	146.39	136.83	121.28	164.39	135.34	129.76	110.69	136.72	145.68	106.83	112.46	116.83	105	103.55	66
Operating Profit	17.76	-5.28	14.13	17.09	19.85	14.73	18.16	21.69	23.58	22.83	6.31	12.16	12.32	10.14	13.16	26	27	24.02	9
OPM %	9.14	-4.48	10.45	9.92	11.94	9.72	13.02	11.66	14.84	14.96	5.39	8.17	7.8	8.67	10.48	18.2	21	18.83	12
Other Income	0.07	0.03	2.56	3.26	0.17	1	2.63	9.67	2.43	0.13	2.39	3.78	2.22	0.44	0.65	2.06	4	2.51	3
Interest	2.67	2.09	2.54	2.77	2.16	2.23	2.18	2.59	2.24	1.94	1.83	1.78	2.24	1.28	0.79	1.29	2	0.99	1
Depreciation	4.42	4.28	4.26	3.87	4	3.85	3.87	3.59	3.27	2.77	3.26	3.24	3.16	3.25	3.05	2.69	3	2.83	3
Profit before tax	10.74	-11.62	9.89	13.71	13.86	9.65	14.74	25.18	20.5	18.25	3.61	10.92	9.14	6.05	9.97	24.08	27	22.71	8
Tax %	13.04	-14.63	24.67	29.39	24.96	23.42	24.69	26.01	23.02	24.55	22.99	26.37	23.96	23.14	23.77	27.28	25	24.79	24
Net Profit	9.34	-9.92	7.45	9.68	10.4	7.38	11.1	18.62	15.79	13.77	2.77	8.04	6.95	4.65	7.6	17.51	20	17.09	6
EPS in Rs	1.94	-2.06	1.54	2.01	2.16	1.53	2.3	3.86	3.28	2.86	0.57	1.67	1.44	0.96	1.58	3.63	4.64	3.95	1.47

Profit and Loss

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	630	615	551	478	492	360	358	313	310	296	326	303	250
Expenses	557	540	499	390	410	313	312	283	274	266	294	260	217
Operating Profit	73	74	52	87	82	47	46	31	36	30	31	43	34
OPM %	12	12	9	18	17	13	13	10	12	10	10	14	13
Other Income	4	15	3	11	18	0	3	9	11	1	-48	2	2
Interest	9	9	6	5	6	9	9	9	14	13	13	14	12
Depreciation	16	13	13	11	10	10	9	9	8	8	10	13	12
Profit before tax	52	68	36	82	83	28	32	23	25	11	-39	17	11
Tax %	26	25	24	25	26	26	24	10	20	0	0	0	0
Net Profit	39	51	27	61	62	21	24	20	20	11	-39	17	11
EPS in Rs	7.99	10.57	5.65	12.66	14.24	4.86	5.55	4.74	4.6	2.48	-9.52	4.4	2.85
Dividend Payout %	38	28	53	24	21	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	42	43	34	-33	60	31	25	26	16	29	46	3	15
Cash from Investing Activity	-56	-44	-13	-84	-25	-13	-25	-11	-18	-9	-10	-9	-9
Cash from Financing Activity	26	1	-20	123	-35	-18	-1	-15	2	-19	-37	7	-12
Net Cash Flow	11	1	2	5	0	0	0	0	0	0	0	0	-7

Balance Sheet

	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	48	48	48	48	48	48	43	43	43	43	43	43	41	39	39
Reserves	453	470	449	443	391	378	202	146	125	101	81	57	49	67	50
Borrowings	157	148	124	99	75	75	66	88	97	89	95	80	86	137	112
Other Liabilities	155	178	126	153	135	110	128	92	85	82	78	84	99	56	63
Total Liabilities	813	844	747	743	650	611	439	370	351	315	298	264	275	299	263
Fixed Assets	235	208	214	182	165	151	112	111	113	104	104	101	102	105	109
CWIP	114	113	83	97	70	36	43	30	24	10	6	3	1	20	20
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1
Other Assets	465	522	450	465	415	425	284	229	214	201	187	160	172	174	134
Total Assets	813	844	747	743	650	611	439	370	351	315	298	264	275	299	263

Delivery

#	Date	107 90% 204	Value (Cr)	Q/T 115	Del 40	Del 21
1	27-May	194	28	74	31	9
2	26-May	194	82	94	23	19
3	25-May	188	227	184	18	41
4	22-May	163	5	55	38	2
5	21-May	167	11	87	39	5
6	20-May	167	22	83	37	8
7	19-May	172	105	123	18	19
8	18-May	165	13	55	40	5
9	15-May	156	1	59	48	1
10	14-May	158	3	60	52	1
11	13-May	154	2	64	46	1
12	12-May	150	4	75	49	2
13	11-May	158	3	79	44	1
14	8-May	162	3	60	47	1
15	7-May	164	2	65	39	1
16	6-May	164	5	81	47	2
17	5-May	162	2	66	52	1
18	4-May	164	5	71	54	3
19	30-Apr	165	6	87	47	3
20	29-Apr	157	1	46	51	1
21	28-Apr	159	3	90	49	1
22	27-Apr	160	2	78	45	1
23	24-Apr	155	2	62	47	1
24	23-Apr	161	5	96	49	3
25	22-Apr	161	6	94	53	3
26	21-Apr	153	3	92	60	2
27	20-Apr	155	2	92	61	1
28	17-Apr	159	12	130	41	5
29	16-Apr	156	3	114	60	2
30	15-Apr	155	3	108	63	2
31	13-Apr	156	3	79	46	2
32	10-Apr	157	5	78	41	2
33	9-Apr	156	20	98	35	7
34	8-Apr	146	14	118	38	5
35	7-Apr	134	39	132	14	6
36	6-Apr	125	3	75	49	1
37	2-Apr	120	3	84	41	1
38	1-Apr	119	3	89	36	1
39	30-Mar	108	5	101	57	3
40	27-Mar	113	5	89	57	3
41	25-Mar	122	4	91	51	2
42	24-Mar	115	3	96	66	2
43	23-Mar	114	4	101	60	2
44	20-Mar	118	3	88	41	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
28-May	938c	17c	1.73
27-May	954c	3c	0.35
26-May	951c	38c	4.20
25-May	913c	101c	12.50
22-May	811c	9c	1.04
21-May	820c	9c	1.05
20-May	811c	6c	0.76
19-May	818c	46c	5.98
18-May	771c	21c	2.73
15-May	751c	5c	0.64
14-May	756c	28c	3.82
12-May	728c	38c	4.98
11-May	766c	33c	4.08
07-May	799c	1c	0.17
06-May	797c	14c	1.75
05-May	784c	28c	3.42
04-May	811c	39c	5.10
30-Apr	772c	4c	0.54
29-Apr	768c	53L	0.07
28-Apr	768c	13c	1.66
24-Apr	756c	24c	3.05
23-Apr	780c	2c	0.30
22-Apr	782c	48c	6.47
21-Apr	734c	29c	3.76
17-Apr	763c	25c	3.40
16-Apr	738c	14c	1.80
15-Apr	751c	0	0

Stock Checklist

Price is above from 52 week high low average: 63%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView